Comparison of the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune) Plasma Among Outpatients With Symptomatic COVID-19
收藏DataCite Commons2026-04-30 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008844/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To assess the efficacy and safety of Human coronavirus immune plasma (HCIP) to reduce the
risk of hospitalization or death, the duration of symptoms and duration of nasopharyngeal or
oropharyngeal viral shedding.
提供机构：
Vivli
创建时间：
2023-03-13
